Invesco Pharmaceuticals ETF holds a quantitatively derived Silver Morningstar Medalist Rating. The rating reflects that it has scored well on factors Morningstar research associates with future outperformance relative to category peers.
Invesco Pharmaceuticals ETF PJP
Morningstar’s Analysis PJP
Will PJP outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 49.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Abbott Laboratories | 5.82 | 30M | Healthcare |
Amgen Inc | 5.64 | 29M | Healthcare |
AbbVie Inc | 5.34 | 27M | Healthcare |
Johnson & Johnson | 5.16 | 26M | Healthcare |
Eli Lilly and Co | 5.15 | 26M | Healthcare |
Merck & Co Inc | 5.13 | 26M | Healthcare |
Pfizer Inc | 4.70 | 24M | Healthcare |
Gilead Sciences Inc | 4.68 | 24M | Healthcare |
Corcept Therapeutics Inc | 4.67 | 24M | Healthcare |
Travere Therapeutics Inc Ordinary Shares | 3.54 | 18M | Healthcare |